IntegReview IRB

IntegReview IRB specializes in providing Institutional Review Board (IRB) services that safeguard human subjects in clinical research, ensuring compliance and protecting ethical standards. Founded in 1999, IntegReview IRB is dedicated to offering comprehensive IRB services. The company is headquartered in Austin, US. In November 2020, it was acquired by Advarra, Inc.

, a portfolio company of Genstar Capital Partners and Linden, enhancing its operational capabilities under new ownership. CEO Melissa Meyer leads the company since its acquisition. IntegReview IRB's primary offerings focus on its Institutional Review Board services, which ensure robust protections for human subjects in clinical research. Their IRB services encompass thorough evaluations of clinical trials, including multisite studies and expedited reviews for minimal risk research.

The company enhances flexibility with a single IRB roster and streamlines communication through the Advarra Center for IRB Intelligence (CIRBI) platform, allowing real-time updates and centralized communication. Clients include institutions, academic medical centers, and hospital systems primarily outside the U. S. , in regions such as Puerto Rico and Canada.

IntegReview IRB generates revenue from its IRB services, which utilize a fee structure based on the complexity and scope of reviews. Transactions primarily occur through B2B partnerships with research institutions and sponsors, retaining services for the duration of clinical trials. The revenue model accommodates various service offerings including full board reviews for multisite studies and expedited reviews for minimal risk protocols, all designed to meet diverse research needs without disclosing specific pricing. Looking forward, IntegReview IRB aims to enhance its service offerings and expand into new markets following its acquisition.

Plans include the launch of new products designed to improve efficiency in the IRB process, although specific release dates have not been provided. The company aims to increase its reach in regions outside the U. S. and Puerto Rico, leveraging recent funding from the acquisition to support these initiatives.

The latest deal occurred in November 2020, when Advarra, Inc. acquired IntegReview IRB, with undisclosed financial terms.